Literature DB >> 11988064

Visualizing cost-effectiveness analysis.

David H Mark.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11988064     DOI： 10.1001/jama.287.18.2428

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

2.  Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.

Authors:  David J Vanness; Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; Ilana F Gareen; Benjamin A Herman; Karen M Kuntz; Ann G Zauber; Marjolein van Ballegooijen; Eric J Feuer; Mei-Hsiu Chen; C Daniel Johnson
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

Review 3.  The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands.

Authors:  Frank van Hees; Ann G Zauber; Harriët van Veldhuizen; Marie-Louise A Heijnen; Corine Penning; Harry J de Koning; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Gut       Date:  2015-06-10       Impact factor: 23.059

4.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Authors:  Amy B Knudsen; Ann G Zauber; Carolyn M Rutter; Steffie K Naber; V Paul Doria-Rose; Chester Pabiniak; Colden Johanson; Sara E Fischer; Iris Lansdorp-Vogelaar; Karen M Kuntz
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

5.  Cost-effectiveness of colorectal cancer screening - an overview.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

Review 6.  Cost-effectiveness of colonoscopy.

Authors:  Ann G Zauber
Journal:  Gastrointest Endosc Clin N Am       Date:  2010-10

7.  Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis.

Authors:  Iris Lansdorp-Vogelaar; Karen M Kuntz; Amy B Knudsen; Janneke A Wilschut; Ann G Zauber; Marjolein van Ballegooijen
Journal:  Ann Intern Med       Date:  2010-09-21       Impact factor: 25.391

8.  Interpreting the results of cost-effectiveness studies.

Authors:  David J Cohen; Matthew R Reynolds
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

9.  Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Authors:  Ann G Zauber; Iris Lansdorp-Vogelaar; Amy B Knudsen; Janneke Wilschut; Marjolein van Ballegooijen; Karen M Kuntz
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

10.  The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.

Authors:  Elisabeth F P Peterse; Reinier G S Meester; Rebecca L Siegel; Jennifer C Chen; Andrea Dwyer; Dennis J Ahnen; Robert A Smith; Ann G Zauber; Iris Lansdorp-Vogelaar
Journal:  Cancer       Date:  2018-05-30       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.